PX1 Research provides laboratory-grade BPC-157 engineered specifically for in vitro and preclinical research applications. Every lot of our synthetically manufactured pentadecapeptide undergoes rigorous analytical verification, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), ensuring uncompromised purity and sequence integrity for tissue repair models.
PX1 Research provides laboratory-grade BPC-157 engineered specifically for in vitro and preclinical research applications. Every lot of our synthetically manufactured pentadecapeptide undergoes rigorous analytical verification, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), ensuring uncompromised purity and sequence integrity for tissue repair models.
Investigators seeking to buy BPC-157 research compound for experimental protocols require analytical transparency, high batch-to-batch consistency, and rigorous sequence verification. BPC-157 is a synthetically derived 15-amino-acid peptide evaluated in preclinical models for accelerating tendon, ligament, muscle, and gut mucosa regeneration through VEGFR2 activation, cellular migration, and localized angiogenesis.
When procuring BPC-157 research peptides, institutional research facilities and academic laboratories must verify that raw materials are synthesized under stringent quality control standards. Impurities generated during solid-phase peptide synthesis (SPPS)—such as truncated sequences, deletion peptides, and residual synthesis reagents—can skew in vitro cellular assays and rodent preclinical data. PX1 Research addresses these strict requirements by supplying American-manufactured reference materials accompanied by public, lot-specific Certificates of Analysis (COAs).
Body Protection Compound 157 (BPC-157) is a partial sequence derived from human gastric juice protein BPC. Composed of 15 amino acids with the primary sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, BPC-157 has a molecular weight of approximately 1419.5 Da. Unlike many endogenous signaling peptides, BPC-157 exhibits remarkable structural stability across a broad pH range, making it a unique subject of study in gastrointestinal and systemic tissue repair models.
In chemical structure assessments, the pentadecapeptide's lack of disulfide bonds simplifies its tertiary conformation, allowing for high solubility in aqueous buffers such as phosphate-buffered saline (PBS) and bacteriostatic water. Researchers studying peptide dynamics in our research library analyze BPC-157 for its resistance to enzymatic degradation, which permits sustained signaling activation in cell culture media and tissue explant preparations.
The primary mechanism underpinning BPC-157 research centers on its interaction with angiogenic pathways. Preclinical studies indicate that BPC-157 upregulates the expression of Vascular Endothelial Growth Factor (VEGF) and activates Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) via phosphorylation. This cascade triggers downstream Akt/eNOS signaling pathways, promoting endothelial cell proliferation, tube formation, and neovascularization in ischemic or injured tissue zones.
Furthermore, in vitro assays demonstrate that BPC-157 interacts with the focal adhesion kinase (FAK) and paxillin pathway, accelerating cellular migration and spreading. Fibroblasts and tenocytes exposed to BPC-157 show enhanced migration rates toward simulated wound borders without unbalancing physiological apoptosis rates. This dual action—promoting vascular growth while facilitating cell recruitment—makes the compound a key focus across our entire catalog of research peptides.
Extensive preclinical investigation has evaluated BPC-157 in rodent models of acute and chronic connective tissue trauma. In transected or crushed Achilles tendon studies, administration of BPC-157 accelerated functional recovery, enhanced load-to-failure mechanical thresholds, and restored structural collagen organization. Histological analyses from these animal models show increased outgrowth of tendon explants and early alignment of Type I collagen fibers over Type III scar-tissue collagen.
Similarly, research in medial collateral ligament (MCL) transection models demonstrates accelerated ligamentous healing. In skeletal muscle injury assays—including muscle crush, transection, and systemic toxin-induced damage—BPC-157 exposure enhanced myoblast proliferation and satellite cell activation. These structural observations suggest that BPC-157 alters matrix metalloproteinase (MMP) expression, balancing tissue remodeling and scar suppression during connective tissue repair.
Beyond musculoskeletal models, BPC-157 was originally isolated in the context of gastric mucosal cytoprotection. In vitro gastrointestinal studies highlight the compound's capacity to preserve gut mucosal integrity when exposed to ulcerogenic agents, non-steroidal anti-inflammatory drugs (NSAIDs), or oxidative stressors. BPC-157 modulates nitric oxide (NO) synthase activity, maintaining localized microvascular blood flow without altering systemic blood pressure parameters.
Preclinical inflammatory bowel disease (IBD) models—such as dextran sulfate sodium (DSS)-induced colitis in rodents—demonstrate that BPC-157 reduces mucosal erosion, attenuates pro-inflammatory cytokine expression (including TNF-alpha and IL-6), and repairs tight junction complexes (occludin and claudin-1). Researchers examining epithelial restitution utilize BPC-157 to decipher the crosstalk between enteric endothelial cells and mucosal stem cell niches.
To establish rigorous comparative research designs, laboratories often evaluate BPC-157 alongside other signaling peptides involved in tissue regeneration and anti-inflammatory cascades. Evaluating these compounds in parallel assays allows investigators to map distinct signaling intersections:
While BPC-157 primarily targets the VEGFR2/FAK pathway to promote cell recruitment and localized microvascular sprouting, TB-500 (a synthetic fragment of Thymosin Beta-4) acts predominantly via actin sequestration to alter cell motility and cytoskeletal remodeling, as detailed in our TB-500 mechanism guide. Simultaneously, GHK-Cu regulates copper-dependent enzyme pathways and gene expression associated with collagen synthesis and remodeling, whereas KPV regulates NF-kB nuclear translocation to suppress inflammatory signaling. Combining or comparing these agents in vitro provides a broader mapping of extracellular matrix (ECM) restoration dynamics.
Proper handling of lyophilized peptides is critical to preserving structural integrity and preventing premature degradation in experimental settings. Upon receiving BPC-157, vials should be stored at -20°C prior to reconstitution. For solubilization, sterile laboratory-grade bacteriostatic water or sterile 0.9% sodium chloride solution should be introduced gently along the inner glass wall of the vial to minimize shear stress on the peptide cake.
Vigorous shaking or vortexing must be avoided; gentle swirl motion is recommended until the lyophilizate dissolves completely into a clear, colorless solution. Reconstituted solutions intended for repeated cell culture dosing over several days should be stored at 2°C to 8°C and protected from light. For step-by-step calculations, dilution tables, and stability timelines, consult our comprehensive BPC-157 reconstitution guide.
A primary challenge when purchasing research peptides online is guaranteeing chemical identity and purity. At PX1 Research, every batch of BPC-157 is subjected to independent third-party analytical testing in ISO 17025 accredited laboratories. Reversely Phase High-Performance Liquid Chromatography (RP-HPLC) verifies that peptide purity meets or exceeds 99.0%, ensuring the absence of secondary synthesis byproducts.
Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular mass matching the target amino acid sequence. Furthermore, because bacterial endotoxins can induce non-specific inflammatory responses in cell cultures and animal tissue models, PX1 Research subjects all peptide lots to Chromogenic LAL Endotoxin Testing. Batches are certified to contain < 0.01 EU/mg, protecting experimental integrity across sensitive bioassays.
Lyophilized BPC-157 exhibits high stability when maintained under appropriate climatic conditions. In its dry, sealed state, the peptide remains stable at room temperature (15°C to 25°C) for short-term transit, but long-term laboratory storage requires controlled environment freezing at -20°C or -80°C to prevent moisture uptake and chemical oxidation over extended months.
Repeated freeze-thaw cycles must be strictly minimized once the peptide is reconstituted into aqueous solution. Aliquoting reconstituted BPC-157 into microcentrifuge tubes before freezing allows researchers to thaw only the exact volumetric quantities required for individual daily assay runs, maintaining concentration accuracy and functional binding kinetics throughout the trial period.
Selecting a qualified peptide vendor involves auditing synthesis standards, testing transparency, and distribution logistics. Academic institutions and commercial laboratories requiring bulk ordering or dedicated account management can utilize our wholesale lab account portal to streamline procurement schedules.
PX1 Research operates within cGMP-compliant facilities in the United States, dispatching orders with same-day fulfillment (Monday through Friday) directly from our dual distribution hubs in California and Arizona. By maintaining strict cold-chain shipping protocols, lot traceability, and published COAs, PX1 Research provides the reliable foundation required for reproducible scientific discovery.
What is BPC-157 and how is it used in laboratory research?
BPC-157 is a synthetic 15-amino-acid pentadecapeptide modeled after a protective sequence found in human gastric juice. In laboratory settings, it is used as a research compound to study focal adhesion kinase pathways, VEGFR2-mediated angiogenesis, and cell migration mechanisms in connective tissue and gastrointestinal mucosal repair models.
How does PX1 Research verify the purity of BPC-157?
PX1 Research verifies BPC-157 purity using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity levels >99.0%, Mass Spectrometry (MS) to verify molecular mass, and LAL assays to confirm endotoxin levels remain below 0.01 EU/mg. Every batch includes a lot-specific Certificate of Analysis (COA).
What liquid should be used to reconstitute BPC-157 for lab protocols?
For in vitro cellular assays and short-term laboratory protocols, sterile bacteriostatic water or sterile 0.9% sodium chloride (saline) solution is standard. Reconstitution should involve gently running the solvent down the glass vial wall and swirling without vortexing.
How should reconstituted BPC-157 be stored in the lab?
Reconstituted liquid BPC-157 solutions should be stored at 2°C to 8°C (refrigerated) for short-term use up to 30 days. For longer storage, aliquot the solution into single-use vials and freeze at -20°C or -80°C to avoid repeated freeze-thaw cycles.
What is the molecular weight and sequence of BPC-157?
BPC-157 has a molecular weight of approximately 1419.5 Da and a 15-amino-acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
How does BPC-157 compare to TB-500 in preclinical models?
While both are studied in tissue repair models, BPC-157 primarily targets the VEGFR2 and FAK pathways to stimulate microvascular sprouting and cell migration. TB-500 (Thymosin Beta-4 fragment) works primarily through actin regulation to mediate cell structure motility and systemic repair pathways.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in cGMP-compliant US facilities and shipped directly from our primary distribution hubs in California and Arizona with same-day fulfillment for orders placed Monday through Friday.
Is BPC-157 approved for human consumption or medical therapy?
No. BPC-157 supplied by PX1 Research is strictly sold as a research chemical for in vitro, cellular, and preclinical laboratory experimentation. It is not for human, veterinary, therapeutic, or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.